SLC2A4 and type 2 diabetes mellitus: PL-MSC therapy remodeled the cytokine efflux and insulin signaling, in addition to enhanced Glut4 expression and glucose uptake, in the skeletal muscle of WNIN/GR-Ob- T2D rats [40].